{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Insitro signs AstraZeneca discovery agreement with $40 million upfront payment","author_name":"techandbusiness.org · AI, Tech & Business","thumbnail_url":"https://s.yimg.com/lo/mysterio/api/6e19d81187d2166bf3fd6b64498793c6c2b962a7c8e954e8d7fd1c8fa3ee18d9/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fbusiness-wire.com%2F71623f087398f900b8f247e951e45aef.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · AI, Tech & Business</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/DGBzUv15adrylE0hncI6fO\" style=\"color:#fff;text-decoration:none;\">Insitro signs AstraZeneca discovery agreement with $40 million upfront payment</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Insitro announced a worldwide exclusive research agreement with AstraZeneca to discover drug targets and therapeutics for metabolic dysfunction-associated steatohepatitis, or MASH, and cardiomyopathie...</p>\n    </blockquote>"}